Guggenheim Yesterday Downgraded Spectrum Pharmaceuticals to Neutral

Guggenheim analyst Michael Schmidt yesterday downgraded Spectrum Pharmaceuticals (NASDAQ:SPPI) from Buy to Neutral.

Benzinga · 12/27/2019 13:11

Guggenheim analyst Michael Schmidt yesterday downgraded Spectrum Pharmaceuticals (NASDAQ:SPPI) from Buy to Neutral.